Product Code: CH 3892
"Shift towards minimally invasive medical procedures is fueling the medical plastics market."
The market size of medical plastics is expected to reach USD 21.06 billion by 2022, at a CAGR of 7.3% between 2017 and 2022. Medical plastics have are lightweight and cost-effective and possess properties such as durability, transparency, barrier properties, and compatibility with other materials. However, government control over healthcare costs may restrain the growth of medical plastics, especially in emerging economies.
"Implants is expected to be the fastest growing application segment of the medical plastics market during the forecast period."
An implant is a medical device that is manufactured to replace a missing natural structure, support a damaged biological structure, or enhance an existing biological structure. The surface of the implants that are in contact with the body might be made of a biomedical material such as titanium, silicone, or apatite depending on what is most functional. The rise in aging population and technological developments are driving the medical plastics market for implants. The implants segment in Asia-Pacific is expected to grow at a high rate over the next few years due to developing healthcare infrastructures, increasing prevalence of chronic diseases, and rising disposable income.
"Asia-Pacific is expected to be the fastest-growing market for medical plastics during the forecast period."
Asia-Pacific is expected to be the fastest-growing market for medical plastics during the forecast period, owing to the increasing demand for medical devices from the aging population. Factors driving the growth of the medical plastics market in Asia-Pacific include Japan's growing medical industry, increasing aging population, rising cosmetic and plastic surgeries in India, increasing cases of cardiovascular diseases, higher domestic demand, availability of raw materials, and cheap labor. The market in Asia-Pacific is more dynamic and competitive than other regions. These factors are expected to drive the demand for medical plastics in the region during the forecast period.
The breakdown of primary interviews is given below:
- By Company Type: Tier 1 - 46%, Tier 2 - 31%, and Tier 3 - 23%
- By Designation: C Level - 54%, D Level - 31%, and Others - 15%
- By Region: North America - 23%, Europe - 31%, Asia-Pacific - 38%, and RoW - 8%
The report also provides company profiles and details competitive strategies adopted by major market players such as Lubrizol (U.S.), Ensinger (Germany), Celanese (U.S.), Trinseo (U.S.), BASF (Germany), and Arkema (France).
Research Coverage:
The market is segmented on the basis of type, application, and region. This report covers the medical plastics market, in terms of volume and value, and forecasts its market size till 2022. The report also provides company profiles and competitive strategies adopted by the key players in the medical plastics market. The report offers detailed information on major factors such as drivers, restraints, opportunities, industry-specific challenges, and winning imperatives influencing the growth of the market.
Reasons to Buy the Report:
The report will help market leaders/new entrants in this market in the following ways:
- 1. The report segments the medical plastics market comprehensively and provides closest approximations of the revenue for the overall market and the subsegments across different verticals and regions.
- 2. The report helps stakeholders understand the pulse of the market and provides information on key market drivers, restraints, opportunities, and challenges.
- 3. The report helps stakeholders understand their competitors better and gain additional insights into the business. The competitive landscape section includes expansions, new product developments, partnerships & collaborations, and mergers & acquisitions.
TABLE OF CONTENTS
1. INTRODUCTION
- 1.1. OBJECTIVES OF THE STUDY
- 1.2. MARKET DEFINITION
- 1.3. MARKET SCOPE
- 1.3.1. YEARS CONSIDERED FOR THE STUDY
- 1.4. CURRENCY
- 1.5. UNIT CONSIDERED
- 1.6. LIMITATIONS
- 1.7. STAKEHOLDERS
2. RESEARCH METHODOLOGY
- 2.1. RESEARCH DATA
- 2.1.1. SECONDARY DATA
- 2.1.1.1. Key data from secondary sources
- 2.1.2. PRIMARY DATA
- 2.1.2.1. Key data from primary sources
- 2.1.2.2. Breakdown of primary interviews
- 2.1.2.3. Key insights from primary interviews
- 2.2. MARKET SIZE ESTIMATION
- 2.2.1.1. Bottom-up approach
- 2.2.1.1. Top-down approach
- 2.3. DATA TRIANGULATION
- 2.4. ASSUMPTIONS
3. EXECUTIVE SUMMARY
4. PREMIUM INSIGHTS
- 4.1. SIGNIFICANT OPPORTUNITIES IN MEDICAL PLASTICS MARKET BETWEEN 2017 AND 2022
- 4.2. MEDICAL PLASTICS MARKET, BY TYPE
- 4.3. MEDICAL PLASTICS MARKET SHARE IN ASIA-PACIFIC, BY APPLICATION AND COUNTRY
- 4.4. MEDICAL PLASTICS MARKET SHARE, BY APPLICATION AND REGION
- 4.5. MEDICAL PLASTICS MARKET ATTRACTIVENESS
5. MARKET OVERVIEW
- 5.1. INTRODUCTION
- 5.2. MARKET DYNAMICS
- 5.2.1. DRIVERS
- 5.2.1.1. Increase in demand for advanced medical technology and devices from aging population
- 5.2.1.2. Shift toward minimally invasive medical procedures
- 5.2.1.3. Rising usage of home healthcare and self-medication
- 5.2.1.4. Growing awareness and government initiatives to provide high-quality healthcare facilities
- 5.2.2. RESTRAINTS
- 5.2.2.1. Government control over healthcare costs
- 5.2.2.2. Variations in regulations across countries and time-consuming approval process
- 5.2.3. OPPORTUNITIES
- 5.2.3.1. Growing healthcare investments in emerging economies
- 5.2.3.2. Innovation and customization of polymers
- 5.2.3.3. Increase in demand for plastics over metals
- 5.2.4. CHALLENGES
- 5.2.4.1. Waste management concerns
- 5.2.4.2. Lack of skilled healthcare professionals
- 5.3. PORTER'S FIVE FORCES ANALYSIS
- 5.3.1. BARGAINING POWER OF SUPPLIERS
- 5.3.2. BARGAINING POWER OF BUYERS
- 5.3.3. THREAT OF SUBSTITUTES
- 5.3.4. THREAT OF NEW ENTRANTS
- 5.3.5. INTENSITY OF COMPETITIVE RIVALRY
- 5.4. MACROECONOMIC OVERVIEW AND KEY TRENDS
- 5.4.1. INTRODUCTION
- 5.4.2. TRENDS AND FORECAST OF GDP
- 5.4.3. TRENDS OF HEALTHCARE INDUSTRY
6. MEDICAL PLASTICS MARKET, BY TYPE
- 6.1. INTRODUCTION
- 6.2. STANDARD PLASTICS
- 6.2.1. POLYVINYL CHLORIDE (PVC)
- 6.2.2. POLYOLEFINS (PO)
- 6.2.2.1. Polyethylene (PE)
- 6.2.2.2. Polypropylene (PP)
- 6.2.3. POLYSTYRENE (PS)
- 6.2.4. POLY(METHYL METHACRYLATE) (PMMA)
- 6.3. ENGINEERING PLASTICS
- 6.3.1. POLYAMIDE (PA)
- 6.3.2. POLYCARBONATE (PC)
- 6.3.3. ACRYLOBUTADIENE STYRENE (ABS)
- 6.3.4. OTHERS ENGINEERING PLASTICS
- 6.4. SILICONE
- 6.5. OTHERS
- 6.5.1. HIGH PERFORMANCE PLASTICS
- 6.5.1.1. Fluoropolymer
- 6.5.1.2. Polyether ether ketone (PEEK)
- 6.5.1.3. Other high performance plastics
- 6.5.2. THERMOPLASTICS ELASTOMER (TPE)
- 6.5.3. THERMOPLASTIC POLYURETHANE (TPU)
7. MEDICAL PLASTICS MARKET, BY APPLICATION
- 7.1. INTRODUCTION
- 7.2. DISPOSABLES
- 7.2.1. CONTACT LENSES
- 7.2.2. HYPODERMIC NEEDLES
- 7.2.3. OTHERS
- 7.3. MEDICAL BAGS
- 7.3.1. BLOOD BAGS
- 7.3.2. URINE BAGS
- 7.3.3. OTHERS
- 7.4. CATHETERS
- 7.4.1. CARDIOVASCULAR CATHETER
- 7.4.2. IV CATHETER
- 7.4.3. URINARY CATHETER
- 7.5. SYRINGES
- 7.5.1. INSULIN SYRINGES
- 7.5.2. TUBERCULIN SYRINGES
- 7.5.3. OTHERS
- 7.6. IMPLANTS
- 7.6.1. BREAST IMPLANTS
- 7.6.2. DENTAL IMPLANTS
- 7.7. SURGICAL INSTRUMENTS
- 7.7.1. CUTTING INSTRUMENTS
- 7.7.2. HEMOSTATIC INSTRUMENTS
- 7.7.3. RETRACTORS
- 7.7.4. OTHERS
- 7.8. DIAGNOSTIC INSTRUMENTS
- 7.8.1. ULTRASOUND AND MRI MACHINES
- 7.8.2. PET & CT SCANNERS
- 7.8.3. X-RAY MACHINES
- 7.9. DENTAL TOOLS
- 7.9.1. EXCAVATORS
- 7.9.2. DENTAL FORCEPS
- 7.10. DRUG DELIVERY DEVICES
- 7.10.1. DRY POWDER INHALER
- 7.10.2. TRANSDERMAL PATCHES
- 7.10.3. NEEDLE-FREE INJECTORS
- 7.10.4. OTHERS
- 7.11. OTHERS
8. MEDICAL PLASTICS MARKET, BY REGION
- 8.1. INTRODUCTION
- 8.2. ASIA-PACIFIC
- 8.2.1. CHINA
- 8.2.2. JAPAN
- 8.2.3. SOUTH KOREA
- 8.2.4. INDIA
- 8.2.5. REST OF ASIA-PACIFIC
- 8.3. EUROPE
- 8.3.1. GERMANY
- 8.3.2. ITALY
- 8.3.3. FRANCE
- 8.3.4. SPAIN
- 8.3.5. U.K.
- 8.3.6. REST OF EUROPE
- 8.4. NORTH AMERICA
- 8.4.1. U.S.
- 8.4.2. CANADA
- 8.4.3. MEXICO
- 8.5. MIDDLE EAST & AFRICA
- 8.5.1. SAUDI ARABIA
- 8.5.2. UAE
- 8.5.3. SOUTH AFRICA
- 8.5.4. REST OF MIDDLE EAST & AFRICA
- 8.6. SOUTH AMERICA
- 8.6.1. BRAZIL
- 8.6.2. ARGENTINA
- 8.6.3. REST OF SOUTH AMERICA
9. COMPETITIVE LANDSCAPE
- 9.1. INTRODUCTION
- 9.2. MARKET RANKING OF KEY PLAYERS
- 9.2.1. LUBRIZOL
- 9.2.2. ENSINGER
- 9.2.3. CELANESE
- 9.2.4. TRINSEO
- 9.2.5. BASF
10. COMPANY PROFILES (Business Overview, Products Offered, Scorecard of Product Offering, Scorecard of Business Strategy, and New Product Launch*)
- 10.1. LUBRIZOL
- 10.2. ENSINGER
- 10.3. CELANESE
- 10.4. TRINSEO
- 10.5. BASF
- 10.6. ARKEMA
- 10.7. BIOMERICS
- 10.8. DSM
- 10.9. EVONIK
- 10.10. ROCHLING
- 10.11. OTHER COMPANIES
- 10.11.1. COVESTRO
- 10.11.2. DUPONT PERFORMANCE POLYMER
- 10.11.3. EASTMAN CHEMICAL COMPANY
- 10.11.4. FREUDENBERG MEDICAL
- 10.11.5. LANXESS
- 10.11.6. LOYNDELLBASELL
- 10.11.7. MODENPLAST
- 10.11.8. NOLATO
- 10.11.9. POLYONE
- 10.11.10. QUADRANT
- 10.11.11. RTP COMPANY
- 10.11.12. SAINT-GOBAIN PERFORMANCE PLASTICS
- 10.11.13. SOLVAY SPECIALTY POLYMERS
- 10.11.14. TEKNOR APEX
- 10.11.15. VICTREX
- 10.11.16. WACKER CHEMIE
*Details might not be captured in case of unlisted companies
11. APPENDIX
- 11.1. INSIGHTS FROM INDUSTRY EXPERTS
- 11.2. DISCUSSION GUIDE
- 11.3. KNOWLEDGE STORE: MARKETSANDMARKETS SUBSCRIPTION PORTAL
- 11.4. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
- 11.5. AVAILABLE CUSTOMIZATIONS
- 11.6. RELATED REPORTS
- 11.7. AUTHOR DETAILS
